Serum LOXL2 is Elevated and an Independent Biomarker in Patients with Coronary Artery Disease

Our data demonstrated that LOXL2 could be a potential biomarker and independent risk factor for CAD patients.

Authors

Institutions

Publication Details

Journal
International Journal of General Medicine
Published
2024-09-01
DOI
https://doi.org/10.2147/ijgm.s478044
Citations
4
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.96
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum LOXL2 is Elevated and an Independent Biomarker in Patients with Coronary Artery Disease

Zhongsheng Zhu
4 citations
International Journal of General Medicine
Atherosclerosis and Cardiovascular Diseases
0.96
article

Serum LOXL2 is Elevated and an Independent Biomarker in Patients with Coronary Artery Disease

Zhongsheng Zhu
article en
4 citations

Abstract

Our data demonstrated that LOXL2 could be a potential biomarker and independent risk factor for CAD patients.

International Journal of General MedicineVol. Volume 17
Pudong Medical Center (CN), Shanghai Traditional Chinese Medicine Hospital (CN), Pudong New Area People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 25%
Atherosclerosis and Cardiovascular Diseases
0.96
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum LOXL2 is Elevated and an Independent Biomarker in Patients with Coronary Artery Disease — Zhongsheng Zhu · International Journal of General Medicine (2024) | TGRS Research Map | TGRS